Short-versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial
M Valgimigli, G Campo, M Monti, P Vranckx… - Circulation, 2012 - Am Heart Assoc
Background—The optimal duration of dual-antiplatelet therapy and the risk-benefit ratio for
long-term dual-antiplatelet therapy after coronary stenting remain poorly defined. We …
long-term dual-antiplatelet therapy after coronary stenting remain poorly defined. We …
Duration of dual antiplatelet therapy after implantation of drug-eluting stents
Background The potential benefits and risks of the use of dual antiplatelet therapy beyond a
12-month period in patients receiving drug-eluting stents have not been clearly established …
12-month period in patients receiving drug-eluting stents have not been clearly established …
Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After …
Background—The optimal duration of dual antiplatelet therapy (DAPT) after implantation of
drug-eluting coronary stents remains undetermined. We aimed to test whether 6-month …
drug-eluting coronary stents remains undetermined. We aimed to test whether 6-month …
Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a randomized, controlled trial
Background—The risks and benefits of long-term dual antiplatelet therapy remain unclear.
Methods and Results—This prospective, multicenter, open-label, randomized comparison …
Methods and Results—This prospective, multicenter, open-label, randomized comparison …
[HTML][HTML] Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents
L Mauri, DJ Kereiakes, RW Yeh… - … England Journal of …, 2014 - Mass Medical Soc
Background Dual antiplatelet therapy is recommended after coronary stenting to prevent
thrombotic complications, yet the benefits and risks of treatment beyond 1 year are …
thrombotic complications, yet the benefits and risks of treatment beyond 1 year are …
Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial
F Feres, RA Costa, A Abizaid, MB Leon, JA Marin-Neto… - Jama, 2013 - jamanetwork.com
Importance The current recommendation is for at least 12 months of dual antiplatelet therapy
after implantation of a drug-eluting stent. However, the optimal duration of dual antiplatelet …
after implantation of a drug-eluting stent. However, the optimal duration of dual antiplatelet …
Effect of 1-month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving …
H Watanabe, T Domei, T Morimoto, M Natsuaki… - Jama, 2019 - jamanetwork.com
Importance Very short mandatory dual antiplatelet therapy (DAPT) after percutaneous
coronary intervention (PCI) with a drug-eluting stent may be an attractive option. Objective …
coronary intervention (PCI) with a drug-eluting stent may be an attractive option. Objective …
Dual antiplatelet therapy after percutaneous coronary intervention and drug-eluting stents: a systematic review and network meta-analysis
Background: The optimal duration of dual antiplatelet therapy (DAPT) after percutaneous
coronary intervention with drug-eluting stents remains uncertain. We compared short-term (< …
coronary intervention with drug-eluting stents remains uncertain. We compared short-term (< …
Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events …
BACKGROUND: The optimal duration of dual antiplatelet therapy after percutaneous
coronary intervention (PCI) is unknown. Incremental reductions in the risk of major adverse …
coronary intervention (PCI) is unknown. Incremental reductions in the risk of major adverse …
[HTML][HTML] Dual antiplatelet therapy after PCI in patients at high bleeding risk
Background The appropriate duration of dual antiplatelet therapy in patients at high risk for
bleeding after the implantation of a drug-eluting coronary stent remains unclear. Methods …
bleeding after the implantation of a drug-eluting coronary stent remains unclear. Methods …